Mmbando, Arnold S.
Ngonzi, Amos J.
Mshamu, Salum
Bradley, John
Bøjstrup, Thomas Chevalier
Ngowo, Halfan S.
Knudsen, Jakob
von Seidlein, Lorenz
Okumu, Fredros O.
Lindsay, Steve W.
Funding for this research was provided by:
Hanako Foundation
Article History
Received: 11 September 2024
Accepted: 12 February 2025
First Online: 14 March 2025
Declarations
:
: The trial was registered to the ClinicalTrials.gov Identifier database with the registration no. NCT04529434. The study was approved by the National Research Ethics Committee of Tanzania with registration number reference NIMR/HQ/R.8a/Vol.IX/3695) and the Department of Biosciences ethics committee, Durham University, UK (approved 24 June 2020). Study participants provided informed consent and those who consented were recruited into the study. The study was conducted in compliance with principles set out by the International Conference on Harmonization Good Clinical Practice, the Declaration of Helsinki and the ethical requirements of Tanzania.
: Not applicable.
: The authors declare no competing interests.